ATE187776T1 - Chemische verbindungen und pharmazeutische zusammensetzungen zur freisetzung von arzneimitteln - Google Patents

Chemische verbindungen und pharmazeutische zusammensetzungen zur freisetzung von arzneimitteln

Info

Publication number
ATE187776T1
ATE187776T1 AT89904951T AT89904951T ATE187776T1 AT E187776 T1 ATE187776 T1 AT E187776T1 AT 89904951 T AT89904951 T AT 89904951T AT 89904951 T AT89904951 T AT 89904951T AT E187776 T1 ATE187776 T1 AT E187776T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
drug release
chemical compounds
release
organism
Prior art date
Application number
AT89904951T
Other languages
English (en)
Inventor
Randell L Mills
Original Assignee
Randell L Mills
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randell L Mills filed Critical Randell L Mills
Application granted granted Critical
Publication of ATE187776T1 publication Critical patent/ATE187776T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/558—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a chemiluminescent acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT89904951T 1988-03-31 1989-03-31 Chemische verbindungen und pharmazeutische zusammensetzungen zur freisetzung von arzneimitteln ATE187776T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17597088A 1988-03-31 1988-03-31
PCT/US1989/001361 WO1989009833A1 (en) 1988-03-31 1989-03-31 Luminide and macroluminide class of pharmaceuticals

Publications (1)

Publication Number Publication Date
ATE187776T1 true ATE187776T1 (de) 2000-01-15

Family

ID=22642405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89904951T ATE187776T1 (de) 1988-03-31 1989-03-31 Chemische verbindungen und pharmazeutische zusammensetzungen zur freisetzung von arzneimitteln

Country Status (7)

Country Link
EP (1) EP0414730B1 (de)
JP (1) JP3025817B2 (de)
AT (1) ATE187776T1 (de)
AU (1) AU3445489A (de)
CA (1) CA1341077C (de)
DE (1) DE68929117T2 (de)
WO (1) WO1989009833A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004340A1 (en) * 1994-08-04 1996-02-15 Gordon George Wallace Conducting electroactive biomaterials
DE10251394A1 (de) * 2002-11-05 2004-05-13 Clariant Gmbh Blaues Farbmittel mit besonders hoher Reinheit und positiver triboelektrischer Steuerwirkung
GB0329161D0 (en) 2003-12-16 2004-01-21 Precisense As Reagant for detecting an analyte
US8063216B2 (en) 2003-12-29 2011-11-22 The Trustees Of Columbia University In The City Of New York Photolabile compounds
WO2010151879A1 (en) * 2009-06-26 2010-12-29 The Trustees Of Columbia University In The City Of New York Photolabile compounds
US9744236B2 (en) 2009-06-26 2017-08-29 The Trustees Of Columbia University In The City Of New York Photolabile compounds
US8231689B2 (en) 2009-11-13 2012-07-31 Warner Babcock Institute For Green Chemistry, Llc Coloring composition containing an aromatic compound and an initiator
WO2011060354A2 (en) * 2009-11-13 2011-05-19 Warner Babcock Institute For Green Chemistry, Llc Coloring composition containing an aromatic compound and an initiator
US8118880B1 (en) 2010-11-15 2012-02-21 Warner Babcock Institute For Green Chemistry, Llc Coloring composition containing L-DOPA and L-arginine and forming a non-covalent derivatization complex
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
CN116763779B (zh) * 2023-04-11 2025-08-26 贵州大学 阳离子桃红及其瓜环复合物在制备预防或治疗抗新型冠状病毒感染药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US784243A (en) 1904-05-28 1905-03-07 Haywood S Winkler Wrench.
US2839542A (en) 1955-03-14 1958-06-17 Chalkley Lyman Quaternary ammonium salts of aminotriphenylmethane acetonitriles
US2839543A (en) 1955-12-02 1958-06-17 Chalkley Lyman Process for preparing cyanides of triarylmethane dyes
US2829148A (en) 1955-12-15 1958-04-01 Chalkley Lyman Purification of cyanides of triarylmethane dyes
US2936235A (en) 1957-03-27 1960-05-10 Chalkley Lyman Photoactivation of aminotriarylmethane dye cyanides
US2885303A (en) 1957-12-13 1959-05-05 Murray S Kaplan Coated fabric
US3798131A (en) * 1972-04-24 1974-03-19 Pasadena Foundation For Medica Assay for polymeric dna as a method for detecting malignancy
EP0110879A1 (de) * 1982-05-26 1984-06-20 The Children's Medical Center Corporation Auskunftsgeberverbindungen
GB8311018D0 (en) * 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4626501A (en) * 1983-09-02 1986-12-02 Integrated Genetics, Inc. Labeled DNA
US4599303A (en) * 1983-12-12 1986-07-08 Hri Associates, Inc. Nucleic acid hybridization assay employing probes crosslinkable to target sequences
GB8405437D0 (en) * 1984-03-01 1984-04-04 Amersham Int Plc Detecting polynucleotide sequences
US4683194A (en) * 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences

Also Published As

Publication number Publication date
AU3445489A (en) 1989-11-03
EP0414730A1 (de) 1991-03-06
EP0414730A4 (en) 1993-06-16
JP3025817B2 (ja) 2000-03-27
CA1341077C (en) 2000-08-08
WO1989009833A1 (en) 1989-10-19
EP0414730B1 (de) 1999-12-15
DE68929117T2 (de) 2000-08-24
DE68929117D1 (de) 2000-01-20
JPH03505574A (ja) 1991-12-05

Similar Documents

Publication Publication Date Title
DE69433818D1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
FI905956A0 (fi) Foerfarande foer producering av ett biologiskt aktivt protein.
ATE427103T1 (de) Orale verabreichung von adenosin analogen
ES2042520T3 (es) Composiciones farmaceuticas que contienen el ester metilico de levodopa, preparacion y aplicaciones terapeuticas del mismo.
ATE187776T1 (de) Chemische verbindungen und pharmazeutische zusammensetzungen zur freisetzung von arzneimitteln
SV1999000049A (es) Nuevas dihidropirimidinas 2 heterociclicamente sustituidas ref. lea 32793-sv
DE69921138D1 (de) Arzneimittel freisetzendes system enthaltend ein homeobox-peptid und ein zytotoxisches oder antineoplastisches mittel
MA26853A1 (fr) Compositions pharmaceutiques engendrant des concentrations accrues de medicaments
DE69330388D1 (de) Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
ATE142116T1 (de) Durch körperliche aktivität gesteuerte vorrichtung zur iontophoretischen verabreichung von medikamenten
DE69935605D1 (de) Ladung und abgabe von wasser unlöslicher arzneimittel
DE69333182D1 (de) Therapeutische konjugate von toxinen und medikamenten
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
DE69431533D1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
DE3880212D1 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
ATE173627T1 (de) Medizinische zusammensetzung
YU156788A (en) Process for producing matrix for releasing and/or dosing healing active material
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
UY25192A1 (es) Formulación medicamentosa con liberación controlada de sustancia activa
NO872659L (no) Farmastiske preparater med galaktitol som bŸrer.
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması
RU96102209A (ru) Лекарственное средство
NO155620C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo(a,d)-cyklohepten-derivater.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee